Epirubicin Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Epirubicin Manufacturers of Epirubicin Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Epirubicin's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 60 to 90 mg/ sq.meter75 (75)As recommended.IVEvery 3 weeks. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Epirubicin is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Epirubicin is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Epirubicin Back to top Manufacturers of Epirubicin in Pakistan Atco Bio Pharma Pfizer Pharmedic Back to top Previous Drug Generic - Next Drug Generic